Journal
GENE
Volume 404, Issue 1-2, Pages 110-116Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.gene.2007.09.005
Keywords
bcl-2 gene transcription; promoter activity; negative regulatory element; lung; airway epithelium
Categories
Funding
- NHLBI NIH HHS [R56 HL068111, HL 68111, R01 HL068111-04, R01 HL068111] Funding Source: Medline
- NIEHS NIH HHS [P30 ES 012072, R01 ES009237, ES 09237, R01 ES015482, P30 ES012072] Funding Source: Medline
Ask authors/readers for more resources
Expression of the anti-apoptotic proto-oncogene bcl-2 is negatively affected by the pro-apoptotic p53. To understand the regulation of bcl-2 expression by p53, we studied the bcl-2 promoter regions individually and in the context of the full-length promoter. While the PI promoter displayed the highest p53-independent activity, the P2 promoter activity was suppressed in p53-sufficient cancer cell lines. In addition, P2 activity was higher in primary airway epithelial cells from p53(-/-) mice compared to those from p53(+/+) mice. Chromatin immunoprecipitation assays confirmed that p53 interacts within a 140 bp sequence of P2 that contained the CCAAT- and TATA-elements. However, when P1 and P2 are linked in one construct, P2 suppressed P1 activity independent of p53. A potential novel promoter with a p53-dependent activity was identified located between P1 and P2, and was designated M. In the context of the full-length bcl-2 promoter, M counteracted in a p53-dependent manner the suppressive activity of P2 on P1. Collectively, these data suggest that P1 promoter is the main driving force for transcribing the bcl-2 gene and P1 activity is modulated by M and P2 in a p53-dependent and -independent manner. These findings may have implications for therapies that are geared towards inhibiting bcl-2 gene expression and inducing cell death. (C) 2007 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available